日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model

XPO1抑制剂联合伊立替康在临床前结直肠癌模型中的疗效

Lentz, Robert W; Dominguez, Adrian T A; Balmaceda, Nicole Baranda; Arcaroli, John J; Bagby, Stacey M; Binns, Cameron A; Smoots, Stephen G; Jackson, Marilyn M; Macbeth, Morgan; Holmstoen, Tessa; Banerjee, Tapahsama; Whitty, Phaedra A; Yi, S Stephen; Lieu, Christopher H; Messersmith, Wells A; Pitts, Todd M

Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer

风险与回报并无二致:不同的化疗方案并不能改善II期早期结肠癌的预后

Leary, Jacob B; Hu, Junxiao; Leal, Alexis; Davis, S Lindsey; Kim, Sunnie; Lentz, Robert; Friedrich, Tyler; Herter, Whitney; Messersmith, Wells A; Lieu, Christopher H

Respect for the Patient-Oncologist Relationship May Limit Serious Illness Communication by Acute and Postacute Care Clinicians After Discharge to a Skilled Nursing Facility

尊重患者与肿瘤科医生之间的关系可能会限制急性期和康复期护理临床医生在患者出院转入专业护理机构后与患者进行严重疾病沟通。

Singh, Sarguni; Dafoe, Ashley; Cagle, John; Messersmith, Wells A; Kessler, Elizabeth R; Lum, Hillary D; Holliman, Brooke Dorsey; Fischer, Stacy

Liver transplantation for colorectal cancer with liver metastases

结直肠癌肝转移的肝移植

Ueberroth, Benjamin E; Kriss, Michael; Burton, James R Jr; Messersmith, Wells A

Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: an Academic Gastrointestinal Cancer Consortium Study

可切除和临界可切除胰腺腺癌的围手术期治疗:一项学术胃肠道癌症联盟研究

Cohen, Deirdre J; Goldberg, Judith D; Leichman, Lawrence; Hochman, Tsivia; Newman, Elliot; Du, Kevin; Megibow, Alec; Oberstein, Paul; Al-Rajabi, Raed; Scott, Aaron J; Bekaii-Saab, Tanios; Messersmith, Wells A; Weekes, Colin

Oligometastatic pancreatic cancer: current state of management and emerging therapies

寡转移性胰腺癌:目前的治疗现状和新兴疗法

Khomiak, Andrii; Balmaceda, Nicole B; Ghaffar, Sumaya A; Lieu, Christopher H; Del Chiaro, Marco; Messersmith, Wells A; Lentz, Robert W

Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer

新型CD47阻断联合疗法治疗难治性微卫星稳定型转移性结直肠癌的II期临床试验和临床前评估

Lentz, Robert W; Lang, Julie; Pitts, Todd M; Blatchford, Patrick; Hu, Junxiao; Jordan, Kimberly R; Van Bokhoven, Adrie; Bagby, Stacey M; Dominguez, Adrian T A; Binns, Cameron A; Robinson, Hannah R; Balmaceda, Nicole; Baiyee, Emily; Leal, Alexis D; Kim, Sunnie S; Davis, S Lindsey; Lieu, Christopher H; Wadlow, Raymond C; Spencer, Kristen; Scott, Aaron J; Boland, Patrick M; Hochster, Howard S; Messersmith, Wells A

Increased accrual of diverse patient populations in oncology phase I clinical trials at the University of Colorado Cancer Center

科罗拉多大学癌症中心肿瘤学I期临床试验中纳入了更多不同类型的患者群体

Alsafar, Ahmed; Kareem, Sama L; Corr, Bradley R; Lieu, Christopher H; Wilky, Breelyn; Davis, S Lindsey; Camidge, D Ross; Jimeno, Antonio; Messersmith, Wells A; Nicklawsky, Andrew; Pacheco, Daniel; Borrayo, Evelinn A; McDermott, Jessica D; Diamond, Jennifer R

Nirogacestat-the pathway to approval of the first treatment for desmoid tumors, a rare disease

Nirogacestat——首个用于治疗罕见病——纤维瘤的疗法获批的途径

Kummar, Shivaani; Bui, Nam; Messersmith, Wells A; Whiting, Jeanne; Portnoy, Marlene; Lim, Allison; Mary, L

Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data

基于高通量单细胞转录组学数据构建的基因调控网络群体水平比较

Osorio, Daniel; Capasso, Anna; Eckhardt, S Gail; Giri, Uma; Somma, Alexander; Pitts, Todd M; Lieu, Christopher H; Messersmith, Wells A; Bagby, Stacey M; Singh, Harinder; Das, Jishnu; Sahni, Nidhi; Yi, S Stephen; Kuijjer, Marieke L